Opportunity Information: Apply for PAR 12 250
Apply for PAR 12 250
- The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Genetic and Genomic Analysis of Xenopus (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173 Research Related to Deafness and Communication Disorders 93.859 Biomedical Research and Research Training 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on Jul 25, 2012 and posted on Jul 25, 2012.
- Applicants must submit their applications by Sep 30, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: For profit organizations other than small businesses City or township governments Independent school districts Private institutions of higher education Native American tribal governments (Federally recognized) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Small businesses County governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Genetic and Genomic Analysis of Xenopus (R01) funding opportunity (PAR 12-250) is an NIH research grant program built to strengthen and expand the use of Xenopus (frog) species as a major vertebrate model for biomedical research. Led by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), with participation from the National Institute on Deafness and Other Communication Disorders (NIDCD), the National Institute of General Medical Sciences (NIGMS), and the Trans-NIH Xenopus Working Group (TXWG), the FOA supports investigator-initiated R01 projects that either create broadly useful Xenopus resources or use cutting-edge genetic and genomic approaches to answer high-impact biological questions. The overall purpose is to make Xenopus even more powerful for discovering how genes and pathways drive development and disease-relevant biology, while also ensuring that the broader research community benefits from new tools, datasets, and methods.
A central emphasis of the announcement is on developing new tools and community resources that enable better detection, manipulation, and characterization of genes, pathways, and phenotypes in Xenopus. Competitive proposals can focus on genetic, genomic, or proteomic resources that the community considers high priority, especially those that accelerate research on development and organ formation (organogenesis), and on core cell biology processes such as cell division, signaling, and cell migration. In practical terms, this could include creating new experimental platforms, reference datasets, molecular reagents, or systematic resources that make it easier to connect genotype to phenotype in Xenopus, or that expand what can be measured and manipulated at the gene, RNA, protein, pathway, tissue, or organism level.
In addition to tool and resource development, the FOA explicitly welcomes projects that use recently developed genetic, genomic, or proteomic technologies to move Xenopus research forward, particularly when the proposed approaches have not been widely used in Xenopus previously. This part of the announcement is aimed at encouraging adoption and adaptation of newer methods in a way that produces clear biological insight, expands the methodological repertoire available to Xenopus investigators, and helps Xenopus remain a leading system for vertebrate functional genomics and mechanistic studies. The intention is not only to generate incremental findings, but to push the model organism forward by bringing in modern technologies and demonstrating their value in Xenopus-based research questions tied to development, organ systems, and fundamental cellular mechanisms.
The mechanism is the NIH R01 (research project grant), and the opportunity is categorized as a discretionary grant program within the broad activity area of health, income security, and social services. It is associated with multiple CFDA numbers reflecting the participating NIH Institutes missions, including 93.173 (deafness and communication disorders), 93.859 (biomedical research and research training), and 93.865 (child health and human development extramural research). There is no cost sharing or matching requirement, which is typical for NIH research grants and means applicants are not expected to commit non-federal matching funds as a condition of the award.
Eligibility is intentionally broad and includes many types of organizations. Eligible applicants include public and private institutions of higher education, nonprofits (with or without 501(c)(3) status, including those other than universities), for-profit organizations (including small businesses and other than small businesses), and a wide range of government entities (state, county, city/township, special district governments, and independent school districts). The FOA also highlights eligibility for organizations that serve specific communities and missions, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and other tribal or regional organizations. Importantly, non-U.S. entities (foreign institutions) are eligible to apply, non-U.S. components of U.S. organizations may participate, and foreign components are allowed consistent with NIH policy, which signals that international expertise and collaborations are acceptable where they strengthen the science and deliverable resources.
From an administrative timeline perspective, the FOA was posted and created on July 25, 2012, with an original and final closing date of September 30, 2014, and an archive date of October 31, 2014. That means this specific announcement is no longer active as written, but it remains a useful reference point for the kinds of Xenopus-focused toolbuilding and functional genomics priorities NIH has supported. The full announcement was hosted by NIH (linked in the source as a grants.nih.gov page), and general technical help for accessing or linking to the FOA was routed through the NIH Office of Extramural Research (OER) webmaster contact.
In short, PAR 12-250 is a targeted NIH R01 opportunity designed to amplify Xenopus as a biomedical research platform by funding either high-value community resources (genetic, genomic, proteomic, and related tools) or research projects that apply modern -omics and genetics methods to uncover genes, pathways, and phenotypes central to vertebrate development, organ formation, and essential cell biological processes. The practical through-line is that funded work should not only answer important questions, but also strengthen what the Xenopus community can do next by improving the experimental and data infrastructure available to the field.
Frequently Asked Questions (FAQs)
What is PAR 12-250, "Genetic and Genomic Analysis of Xenopus (R01)"?
PAR 12-250 is an NIH funding opportunity announcement (FOA) for investigator-initiated R01 research projects focused on strengthening and expanding the use of Xenopus (frog) species as a major vertebrate model for biomedical research. The FOA supports projects that either (1) create broadly useful Xenopus tools and community resources or (2) use advanced genetic, genomic, or proteomic approaches to answer high-impact biological questions in Xenopus.
What is the main purpose of this funding opportunity?
The overall purpose is to make Xenopus an even more powerful system for discovering how genes and pathways drive development and disease-relevant biology, while ensuring the broader research community benefits from new tools, datasets, reagents, and methods that expand what can be measured and manipulated in Xenopus.
Which NIH Institute leads this FOA, and who else participates?
The FOA is led by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Participating organizations include the National Institute on Deafness and Other Communication Disorders (NIDCD), the National Institute of General Medical Sciences (NIGMS), and the Trans-NIH Xenopus Working Group (TXWG).
What grant mechanism does the FOA use?
This opportunity uses the NIH R01 mechanism (Research Project Grant), supporting investigator-initiated research projects.
What kinds of projects are encouraged under this FOA?
The FOA encourages two broad categories of projects: (1) development of Xenopus tools and community resources (genetic, genomic, proteomic, and related) and (2) research projects that apply cutting-edge genetic/genomic/proteomic technologies to generate high-impact biological insights in Xenopus, especially approaches not widely used in Xenopus previously.
What does NIH mean here by "tools" and "community resources"?
Based on the FOA description, tools and resources can include new experimental platforms, reference datasets, molecular reagents, or systematic resources that help connect genotype to phenotype in Xenopus, or that expand measurement and manipulation at the level of genes, RNA, proteins, pathways, tissues, or whole organisms.
What scientific areas are emphasized as especially relevant?
The FOA highlights resources and approaches that accelerate research on development and organ formation (organogenesis), as well as core cell biology processes such as cell division, signaling, and cell migration.
Is the FOA limited to genetics, or does it include other "-omics" approaches?
It is not limited to genetics. The FOA explicitly references genetic, genomic, and proteomic approaches and resources, and it supports projects that broaden the ability to detect, manipulate, and characterize genes, pathways, and phenotypes in Xenopus.
Does the FOA encourage use of new technologies in Xenopus?
Yes. A stated goal is to encourage adoption and adaptation of recently developed genetic, genomic, or proteomic technologies, particularly methods that have not been widely used in Xenopus previously, in ways that produce clear biological insight and expand the methodological repertoire available to Xenopus investigators.
Is the intent to fund incremental findings or more transformative work?
The FOA indicates an intention to push the model organism forward, not only by generating findings but by bringing modern technologies into Xenopus research, demonstrating their value, and strengthening the experimental and data infrastructure available to the field.
What is meant by "investigator-initiated" in this context?
It means applicants propose their own R01 research projects within the scope described by the FOA, rather than responding to a narrowly prescriptive project plan defined by the agency.
What activity area is this grant program associated with?
The opportunity is categorized as a discretionary grant program within the broad activity area of health, income security, and social services.
What CFDA numbers are associated with this FOA?
The FOA is associated with multiple CFDA numbers reflecting participating NIH Institute missions, including 93.173 (deafness and communication disorders), 93.859 (biomedical research and research training), and 93.865 (child health and human development extramural research).
Is cost sharing or matching required?
No. The FOA states there is no cost sharing or matching requirement, meaning applicants are not expected to provide non-federal matching funds as a condition of an award.
Who is eligible to apply?
Eligibility is broad. Eligible applicants include public and private institutions of higher education; nonprofits (with or without 501(c)(3) status, including those other than universities); for-profit organizations (including small businesses and other than small businesses); and a wide range of government entities such as state, county, city/township, special district governments, and independent school districts.
Are minority-serving and tribal institutions explicitly included in eligibility?
Yes. The FOA highlights eligibility for organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and other tribal or regional organizations.
Can non-U.S. (foreign) institutions apply?
Yes. The FOA states that non-U.S. entities (foreign institutions) are eligible to apply. It also allows non-U.S. components of U.S. organizations to participate and permits foreign components consistent with NIH policy.
Does the FOA support international collaborations?
The eligibility language indicates that international expertise and collaborations are acceptable where they strengthen the science and deliverable resources, since foreign institutions and foreign components are allowed consistent with NIH policy.
When was this FOA posted, and is it still active?
The FOA was posted and created on July 25, 2012. It had an original and final closing date of September 30, 2014, and an archive date of October 31, 2014. As written, this specific announcement is no longer active.
If it is archived, why might it still matter?
Even though the FOA is no longer active, it can still serve as a reference for the types of Xenopus-focused tool-building, community resource development, and functional genomics priorities NIH has supported under an R01 mechanism.
Where was the full announcement hosted, and where was technical help directed?
The full announcement was hosted by NIH on a grants.nih.gov page (as referenced in the source). General technical help for accessing or linking to the FOA was routed through the NIH Office of Extramural Research (OER) webmaster contact.
What is the practical through-line NIH is looking for in funded work?
The FOA emphasizes that funded work should both answer important biological questions and strengthen what the Xenopus community can do next by improving experimental tools, datasets, methods, and other shared infrastructure that benefits the broader research community.
Browse more opportunities from the same category: Health Income Security and Social Services
Next opportunity: National Institute of Corrections Inaugural Virtual Conference Event Planning and Delivery
Previous opportunity: Genetic and Genomic Analysis of Xenopus (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 12 250
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 12 250) also looked into and applied for these:
| Funding Opportunity |
|---|
| Development of Mathematical Cognition and Reasoning and the Prevention of Math Learning Disabilities (R21) Apply for PA 12 246 Funding Number: PA 12 246 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Development of Mathematical Cognition and Reasoning and the Prevention of Math Learning Disabilities (R03) Apply for PA 12 247 Funding Number: PA 12 247 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $50,000 |
| Development of Mathematical Cognition and Reasoning and the Prevention of Math Learning Disabilities (R01) Apply for PA 12 248 Funding Number: PA 12 248 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (U54) Apply for RFA AR 13 012 Funding Number: RFA AR 13 012 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Cooperative Multicenter Reproductive Medicine Network (U10) Apply for RFA HD 13 016 Funding Number: RFA HD 13 016 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Global Partnerships for Social Science AIDS Research (R24) Apply for RFA HD 13 012 Funding Number: RFA HD 13 012 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Research Infrastructure for Demographic and Behavioral Population Science (R24) Apply for RFA HD 13 007 Funding Number: RFA HD 13 007 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $150,000 |
| Genomic Sequencing and Newborn Screening Disorders (U19) Apply for RFA HD 13 010 Funding Number: RFA HD 13 010 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,250,000 |
| Human Heredity and Health in Africa (H3Africa) Collaborative Centers (U54) Apply for RFA RM 12 006 Funding Number: RFA RM 12 006 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Prevention of HIV Transmission/Acquisition through a better understanding of Reproductive Health (R01) Apply for RFA HD 13 008 Funding Number: RFA HD 13 008 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Prevention of HIV Transmission/Acquisition through a better understanding of Reproductive Health (R03) Apply for RFA HD 13 009 Funding Number: RFA HD 13 009 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $50,000 |
| Centers for Collaborative Research in Fragile X (U01) Apply for RFA HD 13 004 Funding Number: RFA HD 13 004 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Predoctoral Training Program in Systems Developmental Biology (T32) Apply for PAR 13 019 Funding Number: PAR 13 019 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Data Coordinating Center for the NICHD Cooperative Multicenter Reproductive Medicine Network (U10) Apply for RFA HD 14 018 Funding Number: RFA HD 14 018 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Intellectual and Developmental Disabilities Research Centers 2013 (U54) Apply for RFA HD 13 002 Funding Number: RFA HD 13 002 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Safe and Effective Instruments and Devices for Use in Neonatal and Pediatric Care Settings (R43/R44) Apply for PAR 13 090 Funding Number: PAR 13 090 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Safe and Effective Instruments and Devices for Use in Neonatal and Pediatric Care Settings (R41/R42) Apply for PAR 13 091 Funding Number: PAR 13 091 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Differentiation and Integration of Stem Cells (Embryonic and Induced Pluripotent) Into Developing or Damaged Tissues (R21) Apply for PAR 13 095 Funding Number: PAR 13 095 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Differentiation and Integration of Stem Cells (Embryonic and Induced Pluripotent) Into Developing or Damaged Tissues (R01) Apply for PAR 13 094 Funding Number: PAR 13 094 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $500,000 |
| Evaluation of the Latent Reservoir in HIV Infected Infants and Children with Early Antiretroviral Treatment and Virologic Control (R01) Apply for RFA HD 14 026 Funding Number: RFA HD 14 026 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 12 250", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
